180330-54-5

Basic information

• Product Name: Ethanol, monohydrate
• CAS NO: 180330-54-5
• Molecular Formula: C2H6O.H2O
• Molecular Weight: 64.0843
• Mol File: 180330-54-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Ethanol, monohydrate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanol, monohydrate(180330-54-5)
• EPA Substance Registry System: Ethanol, monohydrate(180330-54-5)

Safety Data

• Hazardous Substances Data: 180330-54-5(Hazardous Substances Data)

Upstream product

• 609-65-4 o-chlorobenzoyl chloride 
• 56-40-6 glycine 
• 31407-28-0 amino-2 carboxamido-3 quinoleine 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 199787-22-9 1,2,3-tri-O-benzoyl-5-O-(4-chlorobenzoyl)-3-C-(2-trimethylsilylethynyl)-α,β-D-ribofuranose 
• 61440-46-8 ethyl p-{{3-[p-(Benzyloxy)phenyl]propyl}amino}benzoate 
• 63650-01-1 ethyl p-{[2-(p-bromophenoxy)ethyl]amino}benzoate 
• 61440-49-1 ethyl 4-(6-phenylhexylamino)benzoate 
• 61439-52-9 p-[(11-phenylundecyl)amino]benzoic acid 
• 61439-65-4 ethyl p-[(p-tridecyloxybenzyl)amino]benzoate 
• 61440-37-7 p-[(9-Phenylnonyl)amino]benzoic Acid 
• 61440-54-8 ethyl p-{[p-(heptyloxy)benzyl]amino}benzoate 
• 61440-57-1 ethyl p-{[(p-decyl)benzyl]amino}benzoate 
• 63673-44-9 p-[(2-phenoxypropyl)amino]benzoic acid 
• 61439-74-5 ethyl p-[(5-phenylpentyl)amino]benzoate 
• 61440-35-5 ethyl p-[(7-phenylheptyl)amino]benzoate 
• 61440-43-5 ethyl p-[3-(o-methoxyphenyl)propyl]aminobenzoate 
• 412357-45-0 N-tert-butoxycarbonyl trans-4-(1-pyrrolidinyl)cyclohexyl-amine 

Relevant articles and documents

6-substituted purine carbocyclic nucleosides

The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. Also provided are pharmaceutical formulations and processes for the preparation of comp

Pharmaceutical compositions and methods of using the same

The present application relates to pharmaceutical compositions incorporating as active ingredient p.chlorohippuric acid or one of its mineral or organic base addition salts. The pharmaceutical compositions are those adapted for parenteral or oral administration. They may include another active ingredient. The present application also extends to therapeutic methods for using the said pharmaceutical compositions namely for protecting the gastric mucosa from acid hypersecretion, ulcers from therapeutic origin and for protecting the liver from toxic aggressions.